NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
BioPorto A/S (CO: BIOPOR)
BIOPOR Technical Analysis
2
As on 21st Nov 2024 BIOPOR STOCK Price closed @ 1.66 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.67 & Strong Buy for SHORT-TERM with Stoploss of 1.32 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BIOPORSTOCK Price
Open | 1.67 | Change | Price | % |
High | 1.76 | 1 Day | -0.01 | -0.60 |
Low | 1.66 | 1 Week | -0.12 | -6.74 |
Close | 1.66 | 1 Month | -0.14 | -7.78 |
Volume | 147108 | 1 Year | 0.56 | 50.91 |
52 Week High 2.96 | 52 Week Low 1.08 |
CO Denmark Most Active Stocks
SAS | 0.01 | 0.00% |
CONFRZ | 0.01 | 0.00% |
NOVO-B | 721.80 | -2.21% |
VWS | 99.26 | -1.72% |
ASTRLS | 1.15 | 8.49% |
AGF-B | 0.71 | 1.43% |
BLVIS-A | 0.40 | -18.37% |
DANSKE | 203.50 | -0.83% |
ALMB | 13.44 | 1.13% |
ISS | 126.20 | -0.86% |
CO Denmark Top Gainers Stocks
CO Denmark Top Losers Stocks
BIOPOR Daily Charts |
BIOPOR Intraday Charts |
Whats New @ Bazaartrend |
BIOPOR Free Analysis |
|
BIOPOR Important Levels Intraday
RESISTANCE | 1.85 |
RESISTANCE | 1.79 |
RESISTANCE | 1.75 |
RESISTANCE | 1.71 |
SUPPORT | 1.61 |
SUPPORT | 1.57 |
SUPPORT | 1.53 |
SUPPORT | 1.47 |
BIOPOR Forecast November 2024
4th UP Forecast | 2.87 |
3rd UP Forecast | 2.48 |
2nd UP Forecast | 2.24 |
1st UP Forecast | 2 |
1st DOWN Forecast | 1.32 |
2nd DOWN Forecast | 1.08 |
3rd DOWN Forecast | 0.84 |
4th DOWN Forecast | 0.45 |
BIOPOR Weekly Forecast
4th UP Forecast | 2.30 |
3rd UP Forecast | 2.09 |
2nd UP Forecast | 1.97 |
1st UP Forecast | 1.84 |
1st DOWN Forecast | 1.48 |
2nd DOWN Forecast | 1.35 |
3rd DOWN Forecast | 1.23 |
4th DOWN Forecast | 1.02 |
BIOPOR Forecast2024
4th UP Forecast | 7.02 |
3rd UP Forecast | 5.3 |
2nd UP Forecast | 4.24 |
1st UP Forecast | 3.18 |
1st DOWN Forecast | 0.14 |
2nd DOWN Forecast | -0.92 |
3rd DOWN Forecast | -1.98 |
4th DOWN Forecast | -3.7 |
BioPorto A/S ( CO Denmark Symbol : BIOPOR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BIOPOR Other Details
Segment | EQ | |
Market Capital | 977302144.00 | |
Sector | Healthcare | |
Industry | Diagnostics & Research | |
Offical website | > echo $website ; ?> |
BIOPOR Address
BIOPOR Latest News
BIOPOR Business Profile
BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company offers the neutrophil gelatinase-associated lipocalin test, a particle-enhanced turbidimetric test that measures NGAL that is used to supplement clinical evaluation and standard tests; monoclonal antibodies for scientific, pharmaceutical, and clinical research use; enzyme-linked immunosorbent assay kits; IVD automated assays; and generic rapid assay device platform for the development of lateral flow assays. It sells its products through own sales team, distributors, and OEM partnerships. The company was founded in 2000 and is headquartered in Hellerup, Denmark. Address: Tuborg Havnevej 15, Hellerup, Denmark, 2900
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service